Cholecystokinin receptors in cells of the immune system.
Lignon
M F
MF
Chimie et Pharmacologie de Molécules d'Intérêt Biologique EP CNRS 51, Faculté de Pharmacie, Montpellier, France.
Bernad
N
N
Martinez
J
J
D001570:Benzodiazepinones / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002460:Cell Line; D002766:Cholecystokinin / Q000031:analogs & derivatives / Q000494:pharmacology; D020109:Devazepide; D006801:Humans; D007700:Kinetics; D008223:Lymphoma; D010671:Phenylurea Compounds; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects; D012844:Sincalide / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D013601:T-Lymphocytes / Q000378:metabolism*; D014407:Tumor Cells, Cultured
D001570:Benzodiazepinones; D010671:Phenylurea Compounds; D011949:Receptors, Cholecystokinin; C075380:JMV 320; C058121:L 365260; D002766:Cholecystokinin; D020109:Devazepide; D012844:Sincalide; D002118:Calcium